The Lead

ACTEMRA Approval Conditions Lifted by Japanese Health Authorities

August 4, 2010 4:53 am | News | Comments

Roche announced today that its partner Chugai has received notification from the Japanese Ministry of Health, Labour and Welfare (MHLW) that the ACTEMRA conditions for approval have been lifted for the rheumatoid arthritis (RA) and polyarticular-course juvenile idiopathic arthritis (pJIA) indications.

FDA Approves ACTEMRA for the Treatment of Moderately to Severely Active Rheumatoid Arthritis

January 11, 2010 3:22 am | News | Comments

Roche today announced that the FDA approved ACTEMRA (tocilizumab, RoACTEMRA in the European Union)...

View Sample

FREE Email Newsletter

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.